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Abstract
Background: The liver X receptors (LXRs) are a family of nuclear receptor transcription factors that are activated by
oxysterols and have defined roles in both lipid metabolism and cholesterol regulation. LXRs also affect antimicrobial
responses and have anti-inflammatory effects in macrophages. As mice lacking LXRs are more susceptible to infection by
intracellular bacteria Listeria monocytogenes and Mycobacterium tuberculosis, we hypothesized that LXR might also influence
macrophage responses to the intracellular protozoan parasite Leishmania chagasi/infantum, a causative agent of visceral
leishmaniasis.
Methods and Findings: Surprisingly, both LXRa knock-out and LXRa/LXRb double-knock-out (DKO) mice were markedly
resistant to systemic L. chagasi/infantum infection compared to wild-type mice. Parasite loads in the livers and spleens of
these animals were significantly lower than in wild-type mice 28 days after challenge. Bone marrow-derived macrophages
from LXR-DKO mice infected with L. chagasi/infantum in vitro in the presence of IFN-c were able to kill parasites more
efficiently than wild-type macrophages. This enhanced killing by LXR-deficient macrophages correlated with higher levels of
nitric oxide produced, as well as increased gene expression of IL-1b. Additionally, LXR ligands abrogated nitric oxide
production in wild-type macrophages in response to infection.
Conclusions: These observations suggest that LXR-deficient mice and macrophages mount antimicrobial responses to
Leishmania infection that are distinct from those mounted by wild-type mice and macrophages. Furthermore, comparison
of these findings to other intracellular infection models suggests that LXR signaling pathways modulate host antimicrobial
responses in a complex and pathogen-specific manner. The LXR pathway thus represents a potential therapeutic target for
modulating immunity against Leishmania or other intracellular parasites.
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Introduction
Liver X receptors (LXRs) are a family of nuclear transcription
factors that play an integral role in both lipid metabolism and the
regulation of inflammation [1,2]. Two isoforms of LXR exist in
both mouse and human: LXRa is mainly expressed in
metabolically active tissues such as liver, intestine, kidney and
adipose tissue, in addition to macrophages and myeloid dendritic
cells (DCs) [3]; LXRb has a relatively ubiquitous expression
pattern [4]. LXRs form functional heterodimers with retinoid X
receptors (RXRs) that are activated upon binding to intracellular
oxysterols, thus functioning as sensors of cellular cholesterol
levels. Upon activation, LXR-RXR complexes promote expres-
sion of genes involved in cholesterol efflux, absorption,
conversion to bile acids, and lipogenesis [5]. In addition to
controlling these key elements of lipid homeostasis, activated
LXR also inhibits the development of inflammatory pathways
via repression of NF-kB signaling, particularly in macrophages
[6]. This dual ability to promote cholesterol efflux and inhibit
inflammation supports a protective function for the LXRs
against diseases such as atherosclerosis, which are characterized
by cholesterol-laden foam cells and chronic inflammation [1].
Consistent with this model, treatment with synthetic LXR
agonist molecules reduces disease incidence in animal models of
atherosclerosis [7]. LXR-deficient mice, conversely, develop
enlarged, cholesterol-laden livers and elevated serum cholesterol
upon exposure to high cholesterol diets, and are highly prone to
atherosclerosis [8].
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In addition to their involvement in the development of these
chronic metabolic diseases, macrophages play a fundamental role
in innate immune activity. The expression of LXR in macro-
phages, combined with the ability of these receptors to regulate
inflammatory pathways, suggest a role for LXR in combating
specific microbial pathogens. Previously it has been demonstrated
that LXR-deficient mice are more susceptible than wild-type mice
to infection with the intracellular bacterial pathogens Listeria
monocytogenes [9] and Mycobacterium tuberculosis [10]. The increased
susceptibility to Listeria was associated with an LXR-regulated gene
expressed in macrophages called SPa, identified as having anti-
apoptotic function. LXR-deficient mice displayed increased
macrophage apoptosis during the course of Listeria infection,
correlating with a decreased ability to clear the bacteria.
Demonstration that LXR-associated pathways impact macro-
phage responses to an intracellular bacterium suggested that these
receptors and their downstream metabolic networks might also
influence immunity against other microbial pathogens.
The genus Leishmania, comprised of numerous distinct species of
trypanosomatid protozoa, infects predominantly macrophage cells
in their mammalian hosts. Leishmania species, particularly L. major,
have been studied in detail over many decades, helping to define
many aspects of host immunity, including initial characterizations
of TH1- versus TH2-type, CD4
+ T cell responses [11]. Invasion of
phagocytic host cells occurs through complex interactions between
Leishmania surface structures and phagocytic receptors in the host
cell [12], which are organized within cholesterol-containing lipid
rafts in the outer membrane. Upon cellular entry, promastigotes
remain in endosomal structures, transform into amastigotes,
multiply, and inhibit immune-mediated clearance by the host
through various mechanisms of immunosuppression [13]. Infected
macrophages and other immune cells express important proin-
flammatory cytokines and molecules that play roles in parasite
resistance, including IL-1, IL-6, IL-12, TNF-a, CD40L, and IFN-
c [14–16]. Also critical to Leishmania immunity is the expression of
inducible nitric oxide synthase (iNOS) by macrophages, which
leads to microbicidal killing via NO production. This pathway is
particularly essential in murine cells [17–19]. Experimental
vaccination regimens in mice that augment immunity against
Leishmania challenge often enhance these pathways, and correlate
with increases in parasite killing.
In this study we examine the role of LXR activity in resistance
to the visceralizing species L. chagasi/infantum, which replicates
primarily in the liver and spleen following intravenous inoculation
in the mouse. Given similarities in pathogenesis of infection
between Leishmania and the bacteria Listeria (liver tropism,
macrophage invasion, intracellular replication, and requirement
for TH1 cellular responses for clearance), we hypothesized that
LXR might also prove important for Leishmania resistance. In
contrast to our published L. monocytogenes results, we demonstrate
here that LXR-deficient mice are more resistant to L. chagasi/
infantum infection compared to wild-type mice. This suggests that
loss of LXR function does not simply lead to a global, general
defect in immunity to intracellular pathogens, and broadens the
implications of LXR modulation in medical therapies. Here we
characterize the increased resistance of LXR-deficient mice to
visceral Leishmania infection, and present data implicating the role
of the macrophage in this phenotype.
Materials and Methods
Mice
Mice were housed in a temperature-controlled room under a
12-hour light/12-hour dark cycle and maintained on standard
chow under specific-pathogen-free conditions. LXRab+/+(wild-
type), LXRa2/2, LXRb2/2, and LXRab 2/2 (DKO) mice were
maintained in a pure C57Bl/6 background, following greater than
20 backcrosses. Knockout and wild-type mice in a mixed
background (Sv129xC57Bl/6) were originally provided by David
Mangelsdorf (University of Texas Southwestern Medical Center,
Dallas, TX) and have been separately backcrossed with each other
since their original creation in 1999. Mice were sex- and age-
matched with littermates for all Leishmania challenge experiments.
Mice ranged in age from 6–12 weeks at the beginning of
experiments. Typical experiments included equal numbers of both
male and female mice, but no significant differences in infection
levels were observed between male and female mice in these
experiments. All mouse experiments were approved by the
Institutional Animal Care and Research Advisory Committee of
UCLA, and the Institutional Animal Care and Use Committee at
Los Angeles Biomedical Research Institute.
Leishmania and in vivo infection
Leishmania chagasi/infantum (MHOM/BR/00/1669), originally
isolated from a patient with visceral leishmaniasis in Northeast
Brazil, was maintained by serial intracardiac injection in outbred
male golden hamsters. Revirilized amastigotes were isolated from
hamster spleens removed from animals infected approximately 3
months prior to euthanasia. Promastigote parasites were grown in
hemoflagellate-modified minimal essential medium (HOMEM)
[20] at 26u, and passaged for no longer than 6 weeks. To enrich
for metacyclic promastigotes, parasites were initially seeded at
36106 cells/mL and grown for 6 days until cultures reached
stationary phase (5276107 cells/mL). Parasites grown in this way
displayed similar infection kinetics, in both mice and macrophag-
es, to parasites enriched for metacyclics by Ficoll gradient
purification, in our hands. Parasites were washed in PBS, counted,
and resuspended at 56107/mL for tail vein injection of 16107
parasites/200 mL. Following specified durations of infection, mice
were euthanized, and parasite burdens were assessed microscop-
ically by blinded counting of Giemsa-stained liver imprints. LDU
Author Summary
Leishmania spp. are protozoan single-cell parasites that are
transmitted to humans by the bite of an infected sand fly,
and can cause a wide spectrum of disease, ranging from
self-healing skin lesions to potentially fatal systemic
infections. Certain species of Leishmania that cause visceral
(systemic) disease are a source of significant mortality
worldwide. Here, we use a mouse model of visceral
Leishmania infection to investigate the effect of a host
gene called LXR. The LXRs have demonstrated important
functions in both cholesterol regulation and inflammation.
These processes, in turn, are closely related to lipid
metabolism and the development of atherosclerosis. LXRs
have also previously been shown to be involved in
protection against other intracellular pathogens that infect
macrophages, including certain bacteria. We demonstrate
here that LXR is involved in susceptibility to Leishmania, as
animals deficient in the LXR gene are much more resistant
to infection with the parasite. We also demonstrate that
macrophages lacking LXR kill parasites more readily, and
make higher levels of nitric oxide (an antimicrobial
mediator) and IL-1b (an inflammatory cytokine) in
response to Leishmania infection. These results could have
important implications in designing therapeutics against
this deadly pathogen, as well as other intracellular
microbial pathogens.
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(Leishman-Donovan units) equals the number of amastigotes per
cell nuclei6 liver weight (in mg).
Macrophage derivation and in vitro infection
Bone marrow-derived macrophages (BMDM) from C57Bl/6
wild-type or LXR-deficient mice were obtained by differentiating
bone marrow cells in complete DMEM/20% FBS supplemented
with M-CSF as described [21]. After 7 days, BMDM were collected
following trypsinization and 16106 cells were allowed to adhere
overnight to coverslips in 12-well plates for infection assays. Primary
peritoneal macrophages were harvested from euthanized animals
following thioglycollate injection as described [22]. For CFSE
labeling of parasites, L. chagasi/infantum promastigotes were
incubated in 5 mM CFSE in PBS for 10 min. at 37u, and washed
twice in PBS. Cells were infected with L. chagasi/infantum
promastigotes (grown to stationary phase to enrich for metacyclics,
as above) at multiplicity of infections (MOI) ranging from 1:1 to 7:1.
Infections were performed in serum-free media, and plates
centrifuged briefly to synchronize infection. After 1 hour of
infection, extracellular parasites were removed by rinsing twice
with PBS, and cells were incubated in fresh medium, at 37u, 5%
CO2 for an additional hour. Macrophage infection levels were
quantitated by microscopy by Giemsa staining cover slips and
counting parasites. A minimum of either 500 amastigotes or
mononuclear cell nuclei were counted per slide, and numbers
reported as amastigotes/nuclei. Alternatively, infected macrophages
were removed from plates, fixed in 2% paraformaldehyde/PBS,
and analyzed by flow cytometry for CFSE (FL-1) positive events.
Nitric oxide assays
Primary macrophages were derived in culture as above. Nitric
oxide production was measured following infection of 16106
macrophages in 12-well plates with L. chagasi/infantum at an MOI
of 5:1 in complete DMEM medium. Designated wells were
preincubated with 10 U/ml recombinant murine IFN-c overnight
for 16–24 hours prior to infection. At varying time points after
initiating infection, supernatants were sampled and assayed for the
accumulation of nitrite ion, which is proportionate to nitric oxide
production, using a Griess Reagent System (Promega). Samples
were analyzed by absorbance photometry at a wavelength of
535 nm and nitrite ion concentration calculated by comparison
with a standard curve of serial dilutions of sodium nitrite.
Leishmania load determination by quantitative PCR
Total genomic DNA was extracted from frozen liver and spleen
samples (,25 mg) from infected animals, using an UltraClean
Tissue DNA Isolation Kit (Mo Bio Laboratories, Inc., Carlsbad,
CA) according to the manufacturer’s instructions. Quantitative
PCR assays were performed using TaqMan probes and TaqMan
Universal PCR Master Mix (Applied Biosystems, Inc.), with
typical 25 mL reactions containing 200 nM of each primer and
probe and 2 mL of genomic DNA template diluted 1:10 following
column elution. L. chagasi/infantum parasite DNA was detected
using primers and probe specific for GP63, a known virulence
gene [23]. Quantitative values of Leishmania were normalized to
levels of a mouse gene (TNF-a) to account for differences in
amounts of tissue sampled. All primers and probes were
synthesized by Integrated DNA Technologies (Coralville, Iowa);
sequences available upon request. PCRs were performed on an
Applied Biosystems Prism 7000 sequence detector, and data was
analyzed using SDS1.2.3 software. GP63 Ct values were converted
to absolute parasite counts using previously determined standard
curves, and were normalized to the amount of tissue DNA in each
sample as determined by TNF-a Ct values.
Real-time RT-PCR to assess gene expression
Total RNA was extracted from tissues or cells growing in vitro
using TRIzol reagent (Invitrogen) and was reverse transcribed to
obtain cDNA (Applied Biosystems). SYBR-based or Taqman-
based real-time quantitative PCR assays were performed using an
Applied Biosystems 7900HT sequence detector as previously
described [24]. Data was normalized to housekeeping genes
RPLP0 (36B4) or HPRT1, both of which were externally verified
as appropriate reference genes under these experimental variables.
Primer sequences are available upon request.
Statistics
Differences between mean values of counted Giemsa-stained
parasites, parasite loads measured by qPCR, and NO levels were
analyzed by a two-tailed Student’s t-test.
Results
LXR-deficient mice have decreased parasite burden
following L. chagasi/infantum infection
We have previously reported that LXRa2/2 and LXRab2/2
(LXR-DKO) mice are more susceptible to Listeria monocytogenes
infection than wild-type control mice [9]. To determine the role of
LXR in the pathogenesis of the macrophage-infecting Leishmania
parasites, we challenged these same knockout mouse strains with the
visceralizing species Leishmania chagasi/infantum. Because of the high
expression levels of LXRa in the liver, we chose to study this visceral
infection model of L. chagasi/infantum, as it is found predominantly in
the liver and spleen of mice following intravenous injection. Wild-
type C57Bl/6 mice display maximal numbers of L. chagasi/infantum
in the liver four weeks after intravenous challenge infection with
stationary-phase promastigotes, followed by subsequent parasite
clearance associated with granuloma formation [25]. Parasite
numbers in the spleen, in contrast, gradually increase over time
and can persist chronically over the life of the animal [26]. We
infected wild-type and LXRa2/2 C57Bl/6 mice intravenously with
virulent, stationary-phase L. chagasi/infantum promastigotes, and
assessed parasite burden in the liver by microscopy four weeks later,
when levels peak in wild-type mice. Mice deficient for LXRa had
significantly decreased parasite burdens compared to wild-type
animals 28 days following challenge (Fig. 1A, p= 0.007). LXRb2/2
mice, compared to wild-type mice, did not exhibit reproducible
differences in parasite load in two experiments (data not shown), and
were not examined further for this study. To determine if these
results were mouse strain-dependent, we also challenged wild-type
and LXR-deficient mice in a mixed strain background,
Sv129xC57Bl/6. All mice, both wild-type and LXR-knockout,
had been backcrossed within this mixed strain for many years and
were therefore congenic. Although mixed background wild-type
mice generally had lower parasite loads than C57Bl/6 wild-type
mice, LXRa2/2 and LXR-DKO mice in the mixed background
also displayed significantly lower parasite loads than their wild-type
littermates (Fig. 1B, LXRa2/2: p = 0.003, LXR-DKO: p=0.003).
To assess the lower parasite levels in the spleen and at earlier
time points after infection, we utilized quantitative PCR (qPCR).
Liver and spleen genomic DNA was harvested and subjected to
Taqman-based qPCR using Leishmania-specific primers and
probes. In agreement with microscopy counts, parasite numbers
were reduced in livers of LXRa2/2 animals compared to wild-
type mice one month after infection (Fig. 1C, p= 0.014). In
addition, parasite numbers measured by qPCR were also reduced
in LXRa2/2 spleens (Fig. 1D, p= 0.06). To determine the level of
Leishmania infection in LXR-KO mice at earlier time points, we
measured parasite levels in these tissues at 3 and 7 days following
LXR Deficiency Increases Leishmania Resistance
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intravenous challenge with L. chagasi/infantum. The amount of
parasite DNA detected in LXRa2/2 livers was significantly lower
on both day 3 and day 7 than the amount detected in wild-type
livers (Fig. 1E, d3: p = 0.002, d7: p = 0.0002). Spleens displayed
relatively low overall levels of parasite DNA at early time points,
but by day 7, parasite loads in wild-type spleens were significantly
higher than in LXRa2/2 spleens (Fig. 1F, d3: p = 0.04, d7:
p = 0.02). Taken together, the differences in organ parasite loads in
LXR-deficient mice suggest that LXR-regulated pathways can
significantly influence the overall control of visceral leishmaniasis
infections.
LXR-deficient macrophages clear parasites more
efficiently than wild-type macrophages in the presence
of IFN-c in vitro
Given the high expression levels of LXRa in macrophages, and
the central role these cells play in Leishmania pathogenesis, we
examined the effect of macrophage LXR deficiency on the kinetics
of parasite uptake and infection in vitro. We differentiated bone
marrow-derived macrophages (BMDM) in vitro for 7 days, then
infected these macrophages with stationary-phase L. chagasi/
infantum promastigotes for 1 hour, before removing any extracel-
lular parasites by washing. Parasites were labeled with the
intracellular dye CFSE to allow for analysis of infected
macrophages by flow cytometry. Two hours following infection,
macrophages from wild-type, LXRa2/2, and DKO mice all
displayed similar patterns of CFSE staining (Fig. 2A), suggesting
that parasite uptake was similar in all cells. We also infected wild-
type and LXR-deficient macrophages grown on cover slips with L.
chagasi/infantum. Giemsa staining and microscopy also revealed
identical percentages of infected cells, as well as identical numbers
of parasites/cell in wild-type, LXRa2/2, and DKO macrophages
(Fig. 2B). These results suggest that LXR does not affect the
process of initial parasite internalization by macrophages in vitro.
We next measured the kinetics of infection and parasite
clearance over time. When macrophages were infected with
Leishmania alone, there was no difference between wild-type and
DKO macrophages in the percentage of infected cells over
48 hours (Fig. 2C, left panel). During in vivo infections, however,
macrophage killing of parasites is known to be dependent on
endogenous IFN-c produced by other cell types, including NK
cells and T cells [16]. We thus repeated in vitro infections by
pretreating macrophages with exogenous IFN-c, in order to
provide a relevant macrophage activating stimulus. In the
presence of IFN-c, DKO macrophages displayed more efficient
clearance of internalized parasites over 48 hours than wild-type
macrophages (Fig. 2C, right panel; p = 0.007 at 48 hr). Interest-
ingly, IFN-c did not appear to enhance parasite clearance in wild-
type macrophages. These results suggest that LXR-dependent
pathways in macrophages partially inhibit the IFN-c-mediated
clearance of Leishmania.
Macrophages from LXR-DKO mice have enhanced NO
secretion
We next examined the effect that LXR deficiency has on
specific parasite defense mechanisms of macrophages. Expression
of inducible nitric oxide synthase (iNOS) by macrophages leads to
nitric oxide (NO) production resulting in destruction of intracel-
lular pathogens [27]. We measured NO production by macro-
phages following Leishmania infection in the presence or absence of
IFN-c in vitro. Without exogenous IFN-c, levels of NO secreted by
BMDM infected with Leishmania parasites over three days
remained low (Fig. 3A, left panel). However, when BMDM were
pretreated with IFN-c before parasite infection, cells from LXR-
DKO mice secreted enhanced levels of NO compared to wild-type
cells (Fig. 3A, right panel). This finding was verified in both
BMDM and peritoneal macrophages (Fig. 3B). The increased level
of NO production by DKO macrophages in the presence of IFN-c
correlates with enhanced clearance of the parasite (Fig. 2C),
suggesting that increased IFN-c-induced NO production by
macrophages may contribute to the enhanced resistance of
LXR-deficient mice to Leishmania infection.
LXR ligands inhibit Leishmania-induced NO from wild-
type macrophages
We hypothesized that if activated LXR complexes are
functioning to downregulate NO production following induction
with IFN-c/Leishmania, then the addition of LXR-activating
ligands to wild-type cells might result in decreased levels of NO
in vitro. Since wild-type BMDM secrete measurable amounts of
NO in response to IFN-c/Leishmania, we tested the ability of LXR
Figure 1. LXR-deficient mice display enhanced resistance to
Leishmania infection of the liver and spleen. Wild-type or LXR-
deficient C57Bl/6 mice (except for (B), which were the mixed
Sv129xC57Bl/6 background) were challenged with 16107 live, station-
ary-phase L. chagasi/infantum parasites, and livers and spleens
harvested at various time points. A–B. Parasite loads in the livers at
d28 were quantitated by microscopy. Leishman-Donovan Units (LDU) =
[(# amastigotes/#mononuclear cells) multiplied by liver weight in mg].
C–F. Parasite loads in liver (C, E) and spleen (D, F) were quantitated by
qPCR of genomic DNA from wild-type (black bars) and LXRa2/2 (white
bars) tissue. Levels are expressed as # parasites/mg tissue. Groups
consisted of 7–9 mice/group for A–D, 5 mice/timepoint for E–F. Results
are representative of at least 3 independent experiments. Error bars
represent standard error; * denotes p,0.05, ** p,0.005, p-value for
Fig. 1D = 0.06, comparisons to wild-type.
doi:10.1371/journal.pntd.0000886.g001
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agonists to inhibit this production. We pre-exposed wild-type
BMDM to the synthetic LXR/RXR ligands GW3965 (GW) and
LG268 (LG) with or without IFN-c overnight prior to incubation
of cells with Leishmania for one hour. The NO produced in wild-
type cells in response to IFN-c/Leishmania was significantly
reduced (by 75%) in cells pretreated with LXR/RXR ligands
(Fig. 4). Pretreatment with L-NNMA, a broad NOS inhibitor, had
similar effects on NO production as GW/LG pretreatment.
Gene expression following Leishmania infection in LXR-
deficient mouse liver and spleen, and macrophages
We assessed the effect of Leishmania infection on mouse tissue
gene expression in vivo, and in macrophages in vitro. Wild-type and
LXRa-KO mice were infected with L. chagasi/infantum 24 or
72 hours before sacrificing, and RNA was harvested from livers
and spleens. LXRa expression in either tissue did not change upon
infection of wild-type mice (as expected, LXRa was not expressed
in LXRa-KO mice), and LXRb was not induced by Leishmania
infection in either wild-type or LXRa-KO mice (Fig. 5A). In
accordance with previously published microarray data in human
and mouse macrophages [14,28], expression of both LXRa and
LXRb was unaltered by Leishmania infection of IFN-c-pretreated
BMDM (Fig. 5B). These results suggest that the Leishmania
resistance observed in LXR-deficient mice cannot be attributed
to a lack of Leishmania-induced upregulation of the LXR genes. We
examined a prototypical LXR-regulated gene, apoE, which
contains an LXR responsive element in its promoter, and is
known to be upregulated upon LXR activation [29]. Baseline
expression levels of apoE, as well as expression following Leishmania
infection (which was decreased), were similar in wild-type and
LXR-DKO macrophages (Fig. 5B). We also examined macro-
phage expression levels of several genes known to be involved in
resistance to visceral Leishmania, including iNOS, IL-1b, IL-6,
TNF-a, and IL-10. Wild-type and DKO BMDM expressed
similar levels of iNOS RNA in response to IFN-c and Leishmania
exposure (Fig. 5B), suggesting that the observed differences in NO
production by wild-type compared to LXR-deficient macrophages
(Fig. 3) are not due to changes in iNOS transcription. Of the
cytokine genes examined, IL-1b was significantly induced by IFN-
c and Leishmania infection in LXR-deficient macrophages, but not
in wild-type macrophages. No other genes examined were
differentially regulated in the absence of LXR, including IL-12
and IFN-c, which were detected only at very low levels by RT-
PCR (data not shown). These results suggest that IL-1b is one
possible cytokine that might contribute to LXR control of
Leishmania resistance during infection.
Discussion
The LXR nuclear receptors regulate both lipid homeostasis and
inflammation in mammalian cells. LXR has emerged as a
potential drug target for chronic metabolic and inflammatory
diseases such as atherosclerosis. Macrophages are central in these
processes, and the expression and activation of both LXR isoforms
in macrophages have been well established. Since macrophages
are innate immune effectors, we and others have begun to
Figure 2. LXR-deficient macrophages are infected similarly, but kill Leishmania more efficiently than wild-type macrophages
treated with IFN-c. Bone marrow-derived macrophages (BMDM) were infected with stationary-phase, (A) CFSE-labeled or (B) unlabelled L. chagasi/
infantum at an MOI of 10:1 for 1 hour, and 2 hours later percentages of infected cells (CFSE-positive events) were determined by (A) flow cytometry
(WT uninfected = gray dotted line; WT infected = black solid line; LXRa2/2 infected = gray solid line; LXR-DKO infected = black dotted line) or (B)
microscopy (the number of parasites per cell was also assessed by microscopy). C. BMDM were infected with stationary-phase, unlabelled L. chagasi/
infantum at an MOI of 20:1 for 2 hours in the presence or absence of IFN-c (overnight pretreatment), and immediately, 24, or 48 hours later were
Giemsa-stained for microscopic quantitation of numbers of amastigotes per cell. Similar results were found in least 3 independent experiments; error
bars represent standard error; * denotes p,0.01.
doi:10.1371/journal.pntd.0000886.g002
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investigate the relationship between these metabolic regulatory
genes and the ability to mount responses against microbial
pathogens. We demonstrate here an unexpected enhanced
resistance of LXR-deficient mice to infection with the intracellular
protozoan Leishmania chagasi/infantum, a parasite that resides and
replicates predominantly in macrophage phagolysosomes. The in
vivo resistance in mice lacking LXRa was evident in the liver as
early as three days following inoculation, and continued over one
month. In accordance with this resistance phenotype, we report
that LXR-deficient macrophages pre-exposed to IFN-c and
infected with L. chagasi/infantum in vitro had fewer intracellular
parasites after 48 hours and produced increased levels of NO
compared to their wild-type counterparts. In addition, IFN-c/
Leishmania-induced NO production by wild-type macrophages
could be inhibited by exposure to LXR ligands. Whereas the in vivo
resistance phenotype was apparent in both LXRa2/2 and LXR-
DKO (LXRab 2/2) mice, the in vitro phenotypes were only
consistently observed in LXR-DKO macrophages, which may
reflect different compensatory abilities of LXRb in vitro versus in
vivo. Overall, we hypothesize that the significantly decreased
parasite burden in LXR-deficient mice might be broadly
attributed to 1) changes in host cell susceptibility to parasite
invasion, establishment, and/or persistence, and/or 2) differences
in functional host immune responses following parasite establish-
ment within macrophages.
The enhanced resistance of both LXRa2/2 and DKO mice to
L. chagasi/infantum was surprising in light of several recent findings
documenting these genotypes’ decreased immunity to various
infections. Our group previously reported that LXR-deficient mice
are acutely susceptible to infection with the bacterium Listeria
monocytogenes [9]. Listeria, like Leishmania, resides intracellularly in
mammalian host cells (including macrophages), and requires TH1-
mediated immune responses for clearance. The absence of LXRa
leads to increased apoptosis of macrophages in response to Listeria
infection, a phenotype attributable in part to decreased expression
of an LXR-regulated, anti-apoptotic factor called SPa [9]. We did
not observe increased apoptosis levels in LXR-deficient BMDM
compared to wild-type macrophages following Leishmania infection
in vitro. One major difference between the two organisms is that
Listeria, unlike Leishmania, escape the phagolysosomal compartment
and enter the host cell cytoplasm. Both Listeria and Shigella flexneri, a
gram-negative intracellular bacterium that also has a cytoplasmic
niche, strongly induce LXRa expression in murine BMDM, in
contrast to extracellular bacteria [9]. Addition of the NOD2 ligand
muramyl dipeptide (MDP) to BMDM also induces expression of
LXRa mRNA, suggesting that specific intracellular signaling
pathways initiated by NOD-like receptors (NLRs) in the cytoplasm
trigger upregulation of LXRa. These pathways are likely not
directly activated by Leishmania in macrophages, as the parasite
normally remains sequestered in phagosomal compartments. Our
results (Figure 5), and microarray data of gene expression patterns
in both human and mouse macrophages, suggest that Leishmania
infection does not affect LXR expression levels or LXR-mediated
gene expression [14,28].
LXR deficiency in mice also results in increased susceptibility to
the intracellular pathogen Mycobacterium tuberculosis [10]. Mice
lacking both isoforms of LXR had decreased clearance of
mycobacterial load from the lungs, spleen and liver over several
weeks of infection. This defect correlated with a reduction of lung-
infiltrating neutrophils in mice lacking LXRa, along with reduced
neutrophil-attracting chemokines. Although typical pro-inflamma-
tory/microbicidal mediators TNF-a and iNOS remained at basal
levels following infection in both wt and KO mice, IL-12p40 levels
were reduced in LXRa KO mice. Interestingly, a significant
Figure 3. LXR-deficient macrophages produce increased levels
of NO following exposure to Leishmania and IFN-c in vitro. A.
BMDM from individual wild-type and DKO (Sv129xC57Bl/6) mice were
stimulated in vitro with stationary-phase L. chagasi/infantum promas-
tigotes for the times indicated, in the absence (left) or presence (right)
of IFN-c pre-treament. B. BMDM (left) or peritoneal macrophages (right)
from wild-type (solid bars) or LXR-DKO (empty bars) mice (C57Bl/6
background) were infected with stationary-phase L. chagasi/infantum
(with or without IFN-c pre-treatment) for 24 hours in vitro. Supernatants
were removed and levels of NO were quantitated by the Griess method.
Error bars represent standard deviations of triplicate NO measurements.
Results are representative of at least 3 independent experiments;
* denotes p,0.05, ** p,0.005.
doi:10.1371/journal.pntd.0000886.g003
Figure 4. NO production by macrophages stimulated with IFN-
c + Leishmania is inhibited by LXR ligands. BMDM were
preincubated overnight with LXR (GW = GW3965) and RXR (LG =
LG268) ligands, with or without IFN-c, prior to a 1 hour in vitro infection
with stationary-phase L. chagasi/infantum. Amount of NO secreted in
24 hours by wild-type BMDM stimulated with IFN-c + Leishmania in the
absence of ligand was normalized to 100%. L-NNMA is a NOS inhibitor.
Error bars represent standard deviations of triplicate NO measurements.
Results are representative of at least 3 independent experiments;
** denotes p,0.005.
doi:10.1371/journal.pntd.0000886.g004
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increase of arginase mRNA was observed in DKO mice, although
it was unclear if this was specific for either isoform, ArgI or ArgII.
The metabolic state of macrophages can directly influence
intracellular growth and/or survival of intracellular amastigotes.
Arginine metabolism is regulated by LXR and has previously been
implicated in Leishmania pathogenesis. The ArgII gene is induced
greater than 50-fold upon ligand activation of LXRa, and its
arginase enzyme product functions to hydrolyze the amino acid
arginine to urea and ornithine [30]. Promotion of this reaction
might influence Leishmania survival within host macrophages in two
distinct ways. First, the products of the arginase pathway are
precursors for polyamine synthesis that positively affect parasite
growth and metabolism [31,32]. Removal of LXRa might lead to
a reduction in these small metabolites that are normally utilized by
amastigotes, leading to inhibited growth and increased suscepti-
bility to oxidative stress. Secondly, nitric oxide synthases (NOS)
compete with arginase enzymes for the utilization of L-arginine as
a substrate, alternatively converting it into NO and L-citrulline.
Previous experiments in our group have demonstrated that
overexpression of ArgII in RAW macrophages in vitro leads to
an inhibition of nitrite production in response to inflammatory
stimuli including LPS, poly I:C, PGN, LTA and CpG [30].
Decreased ArgII expression in LXR-deficient cells, conversely,
might be predicted to lead to an increase in NO production, due
to higher levels of arginine metabolite. We were unable to detect
significant levels of ArgII in wild-type macrophages upon
Leishmania infection, or in mice infected with Leishmania (data not
shown), consistent with the absence of overt upregulation of LXR
by infection. However, the exact role of arginase activity, and its
impact on parasite survival in LXR-deficient animals, will require
further investigation to define.
Specific genes known to be suppressed by activated LXR
include pro-inflammatory cytokines induced by LPS and bacterial
stimuli, including iNOS, cyclooxygenase (COX)-2, and IL-6 [6].
Figure 5. Gene expression in wild-type and LXR-deficient tissues and macrophages following Leishmania infection. A. Wild-type and
LXRa-deficient mice were intravenously challenged with 16107 live, stationary-phase L. chagasi/infantum parasites, and RNA was prepared from livers
and spleens 24 and 72 hours following infection. Real-time RT-PCR was performed with SYBR primers specific for LXRa and LXRb. B. BMDM were
preincubated overnight with IFN-c, infected with stationary-phase Leishmania for 1 hour, washed to remove extracellular parasites, and incubated for
an additional 2 hours. RNA was harvested, and levels of various genes were determined by real-time RT-PCR. Error bars represent standard deviations
of replicate infections; ** denotes p,0.005. Results are representative of at least 3 independent experiments.
doi:10.1371/journal.pntd.0000886.g005
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Early innate cytokine responses by macrophages and neutrophils
determine in part whether Leishmania infections resolve, with Type
I immune responses generally correlating with control of infections
[25]. We demonstrate here that mRNA levels of IL-1b were
higher in LXR-DKO macrophages than in wild-type macrophag-
es following IFN-c pretreatment and L. chagasi infection in vitro.
However, we did not observe differences in macrophage
expression levels of several other cytokines potentially involved
in Leishmania resistance (including IL-6, TNF-a, and IL-10), nor in
levels of iNOS. Enhanced expression of the pro-inflammatory
cytokine IL-1b by macrophages might partially explain the early
resistance of LXR-deficient mice, which displayed lower liver
parasite load as early as three days following challenge. It is clear,
however, that other cell types in addition to macrophages
contribute to the global leishmanial resistance phenotype in vivo.
Bensinger et. al. recently demonstrated a link between LXR
signaling and lymphocyte proliferation, whereby loss of LXRb led
to enhanced T cell responses to antigenic challenge [33]. The
effects of LXR deficiency on other cells, including TH1 CD4
+ T
cells, in terms of Leishmania immunity and cytokine expression, are
currently being studied in our model. Additionally, LXR signaling
was also recently implicated in the clearance of apoptotic cells by
macrophages, and the maintenance of immune tolerance [34].
The relevance of this finding to the observed pathogen immune
phenotypes remains to be defined.
The LXR-regulated network of genes affects many aspects of
metabolism and inflammation, and has been extensively studied
with hopes of positively influencing metabolic disorders such as
hyperlipidemia and atherosclerosis. Mechanisms by which LXR
pathways impact immune function will be important to consider
when targeting these molecules for activation in cardiovascular
disease. With regards to leishmaniasis, understanding how
pathogenesis is impacted by LXR signaling may lead to novel
interventions in this disease process as well. Since LXRs down-
modulate inflammatory pathways, blocking LXR activation or
expression might augment key cell-mediated immune responses
necessary for Leishmania killing. The observation, however, that
LXR-deficient mice, while more resistant to visceral Leishmania
infection, are more susceptible to bacterial infections caused by
Listeria monocytogenes and Mycobacterium tuberculosis, suggests a
complex immune phenotype that is pathogen-dependent. Target-
ing LXR or LXR-mediated genes for antagonism may nonetheless
represent a feasible strategy to modulate immunity against certain
types of intracellular pathogens like Leishmania. Continued study
into the role of LXR in resistance to specific microorganisms may
also lead to enhanced understanding of complex host-pathogen
relationships.
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